Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
FUSED HETEROCYCLIC COMPOUND AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2012/011591
Kind Code:
A1
Abstract:
Disclosed is a compound that has excellent pharmacological activity, physicochemical qualities, and the like, and is useful in the prevention/treatment of eicosanoid-related conditions including arteriosclerosis, diabetes, obesity, atherothrombosis, asthma, fever, pain, cancer, rheumatism, osteoarthritis, and atopic dermatitis. The compound is the compound represented by the belowmentioned formula (each symbol in the formula is as described in the specification) or a salt thereof.

Inventors:
MATSUNAGA NOBUYUKI (JP)
SUZUKI HIDEO (JP)
ASANO KOUHEI (JP)
TOKUHARA HIDEKAZU (JP)
YAMAMOTO TAKESHI (JP)
OKAMOTO REI (JP)
Application Number:
PCT/JP2011/066766
Publication Date:
January 26, 2012
Filing Date:
July 22, 2011
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
TAKEDA PHARMACEUTICAL (JP)
MATSUNAGA NOBUYUKI (JP)
SUZUKI HIDEO (JP)
ASANO KOUHEI (JP)
TOKUHARA HIDEKAZU (JP)
YAMAMOTO TAKESHI (JP)
OKAMOTO REI (JP)
International Classes:
C07D471/04; A61K31/519; A61K31/542; A61P1/00; A61P1/04; A61P1/16; A61P3/04; A61P3/06; A61P3/10; A61P5/00; A61P7/00; A61P7/02; A61P7/06; A61P9/00; A61P9/04; A61P9/06; A61P9/10; A61P9/12; A61P11/00; A61P11/02; A61P11/04; A61P11/06; A61P13/00; A61P13/02; A61P13/08; A61P13/10; A61P13/12; A61P15/08; A61P17/00; A61P17/02; A61P19/00; A61P19/02; A61P21/04; A61P25/00; A61P25/08; A61P25/16; A61P25/18; A61P25/22; A61P25/24; A61P25/28; A61P25/30; A61P25/32; A61P27/02; A61P27/06; A61P29/00; A61P31/00; A61P31/04; A61P31/12; A61P31/16; A61P31/22; A61P33/02; A61P35/00; A61P35/02; A61P35/04; A61P37/08; A61P43/00; C07D475/02; C07D513/04
Domestic Patent References:
WO2005077905A12005-08-25
WO2008089307A22008-07-24
WO2010087467A12010-08-05
WO2007002701A22007-01-04
WO2005091711A22005-10-06
WO2003106435A12003-12-24
WO2002006264A12002-01-24
WO2003059900A12003-07-24
WO2002006234A12002-01-24
WO2004048363A12004-06-10
WO2005030740A12005-04-07
WO2005058823A12005-06-30
WO2005113504A12005-12-01
WO2001038325A12001-05-31
WO2001025228A12001-04-12
WO2003042204A12003-05-22
WO1998044921A11998-10-15
WO1998045285A11998-10-15
WO1999022735A11999-05-14
WO2001014372A22001-03-01
Foreign References:
JP2008504301A2008-02-14
US5925642A1999-07-20
JP2010166475A2010-07-29
JP2011122796A2011-06-23
Other References:
See also references of EP 2597095A4
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 19, no. 17, 2009, pages 5200 - 5204
SYNTHESIS, no. 23, 2007, pages 3678 - 3682
ARZNEIMITTEL FORSCHUNG, vol. 56, no. 6, 2006, pages 377 - 381
INDIAN JOURNAL OF CHEMISTRY, SECTION B: ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, vol. 39B, no. 3, 2000, pages 210 - 214
JOURNAL OF THE INSTITUTION OF CHEMISTS, vol. 57, no. 4, 1985, pages 156 - 158
"Design of Molecules", vol. 7, 1990, HIROKAWA SHOTEN, article "IYAKUHIN NO KAIHATSU", pages: 163 - 198
CHEMICAL AND PHARMACEUTICAL BULLETIN, vol. 43, 1995, pages 788
"Protective Groups in Organic Synthesis", 1980, JOHN WILEY AND SONS
BLIGH; DYER, CAN. J. BIOCHEM. PHYSIOL., vol. 37, 1959, pages 911
Attorney, Agent or Firm:
TAKASHIMA, HAJIME (JP)
Takashima 1 (JP)
Download PDF:
Claims: